Lineage Cell Therapeutics In shares owned by Founders Capital Management
Quarter-by-quarter ownership of Lineage Cell Therapeutics In (LCTX) shares owned by Founders Capital Management
from 13F filings
Historical chart of Founders Capital Management investment in Lineage Cell Therapeutics In
Tip: Access up to 7 years of quarterly data
All positions including Lineage Cell Therapeutics In held by Founders Capital Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Lineage Cell Therapeutics In by Founders Capital Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-03-31 | $12k | 8.0k | 1.48 |
| 2023-12-31 | $8.7k | 8.0k | 1.09 |
| 2023-09-30 | $9.4k | 8.0k | 1.18 |
| 2023-06-30 | $11k | 8.0k | 1.41 |
| 2023-03-31 | $12k | 8.0k | 1.50 |
| 2022-12-31 | $9.0k | 8.0k | 1.13 |
| 2022-09-30 | $9.0k | 8.0k | 1.13 |
| 2022-06-30 | $13k | 8.0k | 1.63 |
| 2022-03-31 | $20k | 8.0k | 2.50 |
| 2021-12-31 | $20k | 8.0k | 2.50 |
| 2021-09-30 | $13k | 5.0k | 2.62 |
| 2021-06-30 | $14k | 5.0k | 2.82 |
| 2021-03-31 | $6.0k | 5.0k | 1.21 |
| 2020-12-31 | $9.0k | 5.0k | 1.81 |
| 2020-03-31 | $4.0k | 5.0k | 0.80 |
| 2019-12-31 | $4.0k | 5.0k | 0.80 |
| 2019-09-30 | $5.0k | 5.0k | 1.01 |
More positions owned by Founders Capital Management
View all positions for Founders Capital Management